Medtronic Insider Sales Reveal Strategic Portfolio Shift, Not Crisis
Medtronic insider sales: Marinaro sells 10,420 shares, CEO sells 50,000, reflecting routine portfolio shifts amid post‑MiniMed split focus.
3 minutes to read
Medtronic PLC
Medtronic Insider Sale Signals Strategic Shift Amid FDA Clearance
Medtronic insider Harry Skip sells shares after FDA clearance of LigaSure® RAS for the Hugo platform, hinting at a strategic portfolio shift while market buzz spikes.
3 minutes to read
Medtronic Insider Sale Signals Strategic Liquidity Ahead of MiniMed Spin‑Off
Denise Blomquist’s €81/share sale of 600 Medtronic shares amid the MiniMed spin‑off shows cautious insider liquidity, not distress—track future moves for investment insight.
3 minutes to read